PSA Levels and the Probability of Prostate Cancer on Biopsy-Reference-Cited by-同舟云学术

PSA Levels and the Probability of Prostate Cancer on Biopsy

Published:2002-09 Issue:6 Volume:1 Page:21-27
ISSN:1569-9056
Container-title:European Urology Supplements
language:en
Short-container-title:European Urology Supplements

Author:

Gretzer Matthew B,Partin Alan W

Publisher

Elsevier BV

Subject

Urology

Reference58 articles.

1. Cancer statistics, 1999;Landis;CA Cancer J. Clin.,1999

2. Comparison of digital rectal examination and serum prostate-specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men;Catalona;J. Urol.,1994

3. Comparison of prostate-specific antigen concentration versus prostate-specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves;Catalona;J. Urol.,1994

4. Prostate cancer screening: current trends and future implications;Littrup;CA Cancer J. Clin.,1992

5. Carter HB, Partin AW. Diagnosis and staging of prostate cancer. In: Walsh PC, et al., editors. Campbell’s urology. Philadelphia: Saunders, 1998. p. 2519.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic utility of prostate health index density prior to MRI-ultrasound fusion targeted biopsy;Exploration of Targeted Anti-tumor Therapy;2024-09-13

2. A cost-benefit analysis of mass prostate cancer screening;Cost Effectiveness and Resource Allocation;2024-05-05

3. Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results;JAMA Network Open;2023-11-29

4. Urinary endogenous peptides as biomarkers for prostate cancer;Oncology Letters;2023-03-14

5. Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study;BMC Medical Genomics;2022-05-05